Streetbeat News

Earnings

GHSI

Guardion Health Sciences (NASDAQ:GHSI) reported a significant increase in Q3 earnings to $0.29 per share from a loss of $(0.67) per share YoY. Sales also increased by 25.27% to $3.34M, surpassing the $3.08M estimate.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:38 pm

MDWT

Midwest Holding reported a significant decrease in earnings per share (EPS) for Q3 2023, with EPS at $0.10 compared to $1.96 year-over-year. Revenue for the quarter was $16.419 million, falling short of the estimated $18.6 million.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:38 pm

KTRA

Kintara Therapeutics (NASDAQ:KTRA) reported a Q1 EPS loss of $(1.83), significantly missing the analyst consensus estimate of $(0.58) by 215.52%. However, this represents a 47.71% improvement from the $(3.50) per share loss reported in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:37 pm

ZOM

Zomedica (AMEX:ZOM) reported a narrower Q3 loss of $(0.00) per share compared to $(0.01) per share in the same quarter last year, an 80% improvement. However, Q3 sales of $6.35M fell short of the $8.28M analyst consensus, a 23.35% miss, despite being a 32.89% increase from $4.78M in the prior year.

Portfolio Pulse from mahesh@benzinga.com

November 13, 2023 | 10:36 pm

CING

Cingulate reported an improvement in its Q3 2023 earnings per share (EPS) to $(0.30) from $(0.36) year-over-year (YoY).

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:36 pm

CNTA

Centessa Pharmaceuticals (NASDAQ:CNTA) reported a Q3 EPS loss of $(0.40), surpassing the analyst consensus estimate of $(0.52) by 23.08%. The reported loss shows a 29.82% improvement from the $(0.57) per share loss in the same quarter of the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:35 pm

ATXI

Avenue Therapeutics (NASDAQ:ATXI) reported a significant increase in quarterly earnings, posting $0.06 per share compared to a loss of $(0.45) per share year-over-year, marking a 113.33% improvement.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:35 pm

YMAB

Y-mAbs Therapeutics (NASDAQ:YMAB) reported Q3 earnings with an EPS of $(0.18), slightly better than the $(0.19) estimate, marking a 71.43% improvement from last year. However, sales of $19.95M fell short of the $20.93M estimate, despite being 59.16% higher than the previous year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:34 pm

USEG

U.S. Energy reported a Q3 2023 EPS of $(0.35), a decrease from the $0.16 reported in the same quarter last year. However, the company's revenue of approximately $8.7 million exceeded the estimate of $8.180 million.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:34 pm

RZLT

Rezolute (NASDAQ:RZLT) reported Q1 EPS losses of $(0.28), which met analyst consensus estimates but marked a 47.37% increase in losses from $(0.19) per share in the same quarter last year.

Portfolio Pulse from Benzinga Newsdesk

November 13, 2023 | 10:32 pm